[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Human Coagulation Factor VIII Consumption Market Report

August 2018 | 161 pages | ID: 2409BE766BAEN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Human Coagulation Factor VIII market for 2018-2023.

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.
North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.

The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.

Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.

Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.

Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.

Over the next five years, LPI(LP Information) projects that Human Coagulation Factor VIII will register a 2.8% CAGR in terms of revenue, reach US$ 8770 million by 2023, from US$ 7440 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor VIII market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Segmentation by application:
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Human Coagulation Factor VIII consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Human Coagulation Factor VIII market by identifying its various subsegments.
  • Focuses on the key global Human Coagulation Factor VIII manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Human Coagulation Factor VIII with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Human Coagulation Factor VIII submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Coagulation Factor VIII Consumption 2013-2023
  2.1.2 Human Coagulation Factor VIII Consumption CAGR by Region
2.2 Human Coagulation Factor VIII Segment by Type
  2.2.1 Recombinant Factor VIII
  2.2.2 Plasma-derived Factor VIII
2.3 Human Coagulation Factor VIII Consumption by Type
  2.3.1 Global Human Coagulation Factor VIII Consumption Market Share by Type (2013-2018)
  2.3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Human Coagulation Factor VIII Sale Price by Type (2013-2018)
2.4 Human Coagulation Factor VIII Segment by Application
  2.4.1 Hemophilia A
  2.4.2 Spontanous / Trauma
  2.4.3 Surgical
  2.4.4 Other
2.5 Human Coagulation Factor VIII Consumption by Application
  2.5.1 Global Human Coagulation Factor VIII Consumption Market Share by Application (2013-2018)
  2.5.2 Global Human Coagulation Factor VIII Value and Market Share by Application (2013-2018)
  2.5.3 Global Human Coagulation Factor VIII Sale Price by Application (2013-2018)

3 GLOBAL HUMAN COAGULATION FACTOR VIII BY PLAYERS

3.1 Global Human Coagulation Factor VIII Sales Market Share by Players
  3.1.1 Global Human Coagulation Factor VIII Sales by Players (2016-2018)
  3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Players (2016-2018)
3.2 Global Human Coagulation Factor VIII Revenue Market Share by Players
  3.2.1 Global Human Coagulation Factor VIII Revenue by Players (2016-2018)
  3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Players (2016-2018)
3.3 Global Human Coagulation Factor VIII Sale Price by Players
3.4 Global Human Coagulation Factor VIII Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Human Coagulation Factor VIII Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Human Coagulation Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 HUMAN COAGULATION FACTOR VIII BY REGIONS

4.1 Human Coagulation Factor VIII by Regions
  4.1.1 Global Human Coagulation Factor VIII Consumption by Regions
  4.1.2 Global Human Coagulation Factor VIII Value by Regions
4.2 Americas Human Coagulation Factor VIII Consumption Growth
4.3 APAC Human Coagulation Factor VIII Consumption Growth
4.4 Europe Human Coagulation Factor VIII Consumption Growth
4.5 Middle East & Africa Human Coagulation Factor VIII Consumption Growth

5 AMERICAS

5.1 Americas Human Coagulation Factor VIII Consumption by Countries
  5.1.1 Americas Human Coagulation Factor VIII Consumption by Countries (2013-2018)
  5.1.2 Americas Human Coagulation Factor VIII Value by Countries (2013-2018)
5.2 Americas Human Coagulation Factor VIII Consumption by Type
5.3 Americas Human Coagulation Factor VIII Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Human Coagulation Factor VIII Consumption by Countries
  6.1.1 APAC Human Coagulation Factor VIII Consumption by Countries (2013-2018)
  6.1.2 APAC Human Coagulation Factor VIII Value by Countries (2013-2018)
6.2 APAC Human Coagulation Factor VIII Consumption by Type
6.3 APAC Human Coagulation Factor VIII Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Human Coagulation Factor VIII by Countries
  7.1.1 Europe Human Coagulation Factor VIII Consumption by Countries (2013-2018)
  7.1.2 Europe Human Coagulation Factor VIII Value by Countries (2013-2018)
7.2 Europe Human Coagulation Factor VIII Consumption by Type
7.3 Europe Human Coagulation Factor VIII Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Coagulation Factor VIII by Countries
  8.1.1 Middle East & Africa Human Coagulation Factor VIII Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Human Coagulation Factor VIII Value by Countries (2013-2018)
8.2 Middle East & Africa Human Coagulation Factor VIII Consumption by Type
8.3 Middle East & Africa Human Coagulation Factor VIII Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Human Coagulation Factor VIII Distributors
10.3 Human Coagulation Factor VIII Customer

11 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET FORECAST

11.1 Global Human Coagulation Factor VIII Consumption Forecast (2018-2023)
11.2 Global Human Coagulation Factor VIII Forecast by Regions
  11.2.1 Global Human Coagulation Factor VIII Forecast by Regions (2018-2023)
  11.2.2 Global Human Coagulation Factor VIII Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Human Coagulation Factor VIII Forecast by Type
11.8 Global Human Coagulation Factor VIII Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Shire (Baxter)
  12.1.1 Company Details
  12.1.2 Human Coagulation Factor VIII Product Offered
  12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Shire (Baxter) News
12.2 Bayer
  12.2.1 Company Details
  12.2.2 Human Coagulation Factor VIII Product Offered
  12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Bayer News
12.3 CSL
  12.3.1 Company Details
  12.3.2 Human Coagulation Factor VIII Product Offered
  12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 CSL News
12.4 Pfizer
  12.4.1 Company Details
  12.4.2 Human Coagulation Factor VIII Product Offered
  12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Pfizer News
12.5 Grifols
  12.5.1 Company Details
  12.5.2 Human Coagulation Factor VIII Product Offered
  12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Grifols News
12.6 Biogen
  12.6.1 Company Details
  12.6.2 Human Coagulation Factor VIII Product Offered
  12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Biogen News
12.7 Octapharma
  12.7.1 Company Details
  12.7.2 Human Coagulation Factor VIII Product Offered
  12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Octapharma News
12.8 NovoNordisk
  12.8.1 Company Details
  12.8.2 Human Coagulation Factor VIII Product Offered
  12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 NovoNordisk News
12.9 Greencross
  12.9.1 Company Details
  12.9.2 Human Coagulation Factor VIII Product Offered
  12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Greencross News
12.10 Kedrion
  12.10.1 Company Details
  12.10.2 Human Coagulation Factor VIII Product Offered
  12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Kedrion News
12.11 BPL
12.12 Hualan Bio
12.13 RAAS

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Human Coagulation Factor VIII
Table Product Specifications of Human Coagulation Factor VIII
Figure Human Coagulation Factor VIII Report Years Considered
Figure Market Research Methodology
Figure Global Human Coagulation Factor VIII Consumption Growth Rate 2013-2023 (K Units)
Figure Global Human Coagulation Factor VIII Value Growth Rate 2013-2023 ($ Millions)
Table Human Coagulation Factor VIII Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Recombinant Factor VIII
Table Major Players of Recombinant Factor VIII
Figure Product Picture of Plasma-derived Factor VIII
Table Major Players of Plasma-derived Factor VIII
Table Global Consumption Sales by Type (2013-2018)
Table Global Human Coagulation Factor VIII Consumption Market Share by Type (2013-2018)
Figure Global Human Coagulation Factor VIII Consumption Market Share by Type (2013-2018)
Table Global Human Coagulation Factor VIII Revenue by Type (2013-2018) ($ million)
Table Global Human Coagulation Factor VIII Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Human Coagulation Factor VIII Value Market Share by Type (2013-2018)
Table Global Human Coagulation Factor VIII Sale Price by Type (2013-2018)
Figure Human Coagulation Factor VIII Consumed in Hemophilia A
Figure Global Human Coagulation Factor VIII Market: Hemophilia A (2013-2018) (K Units)
Figure Global Human Coagulation Factor VIII Market: Hemophilia A (2013-2018) ($ Millions)
Figure Global Hemophilia A YoY Growth ($ Millions)
Figure Human Coagulation Factor VIII Consumed in Spontanous / Trauma
Figure Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2013-2018) (K Units)
Figure Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2013-2018) ($ Millions)
Figure Global Spontanous / Trauma YoY Growth ($ Millions)
Figure Human Coagulation Factor VIII Consumed in Surgical
Figure Global Human Coagulation Factor VIII Market: Surgical (2013-2018) (K Units)
Figure Global Human Coagulation Factor VIII Market: Surgical (2013-2018) ($ Millions)
Figure Global Surgical YoY Growth ($ Millions)
Figure Human Coagulation Factor VIII Consumed in Other
Figure Global Human Coagulation Factor VIII Market: Other (2013-2018) (K Units)
Figure Global Human Coagulation Factor VIII Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Human Coagulation Factor VIII Consumption Market Share by Application (2013-2018)
Figure Global Human Coagulation Factor VIII Consumption Market Share by Application (2013-2018)
Table Global Human Coagulation Factor VIII Value by Application (2013-2018)
Table Global Human Coagulation Factor VIII Value Market Share by Application (2013-2018)
Figure Global Human Coagulation Factor VIII Value Market Share by Application (2013-2018)
Table Global Human Coagulation Factor VIII Sale Price by Application (2013-2018)
Table Global Human Coagulation Factor VIII Sales by Players (2016-2018) (K Units)
Table Global Human Coagulation Factor VIII Sales Market Share by Players (2016-2018)
Figure Global Human Coagulation Factor VIII Sales Market Share by Players in 2016
Figure Global Human Coagulation Factor VIII Sales Market Share by Players in 2017
Table Global Human Coagulation Factor VIII Revenue by Players (2016-2018) ($ Millions)
Table Global Human Coagulation Factor VIII Revenue Market Share by Players (2016-2018)
Figure Global Human Coagulation Factor VIII Revenue Market Share by Players in 2016
Figure Global Human Coagulation Factor VIII Revenue Market Share by Players in 2017
Table Global Human Coagulation Factor VIII Sale Price by Players (2016-2018)
Figure Global Human Coagulation Factor VIII Sale Price by Players in 2017
Table Global Human Coagulation Factor VIII Manufacturing Base Distribution and Sales Area by Players
Table Players Human Coagulation Factor VIII Products Offered
Table Human Coagulation Factor VIII Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Human Coagulation Factor VIII Consumption by Regions 2013-2018 (K Units)
Table Global Human Coagulation Factor VIII Consumption Market Share by Regions 2013-2018
Figure Global Human Coagulation Factor VIII Consumption Market Share by Regions 2013-2018
Table Global Human Coagulation Factor VIII Value by Regions 2013-2018 ($ Millions)
Table Global Human Coagulation Factor VIII Value Market Share by Regions 2013-2018
Figure Global Human Coagulation Factor VIII Value Market Share by Regions 2013-2018
Figure Americas Human Coagulation Factor VIII Consumption 2013-2018 (K Units)
Figure Americas Human Coagulation Factor VIII Value 2013-2018 ($ Millions)
Figure APAC Human Coagulation Factor VIII Consumption 2013-2018 (K Units)
Figure APAC Human Coagulation Factor VIII Value 2013-2018 ($ Millions)
Figure Europe Human Coagulation Factor VIII Consumption 2013-2018 (K Units)
Figure Europe Human Coagulation Factor VIII Value 2013-2018 ($ Millions)
Figure Middle East & Africa Human Coagulation Factor VIII Consumption 2013-2018 (K Units)
Figure Middle East & Africa Human Coagulation Factor VIII Value 2013-2018 ($ Millions)
Table Americas Human Coagulation Factor VIII Consumption by Countries (2013-2018) (K Units)
Table Americas Human Coagulation Factor VIII Consumption Market Share by Countries (2013-2018)
Figure Americas Human Coagulation Factor VIII Consumption Market Share by Countries in 2017
Table Americas Human Coagulation Factor VIII Value by Countries (2013-2018) ($ Millions)
Table Americas Human Coagulation Factor VIII Value Market Share by Countries (2013-2018)
Figure Americas Human Coagulation Factor VIII Value Market Share by Countries in 2017
Table Americas Human Coagulation Factor VIII Consumption by Type (2013-2018) (K Units)
Table Americas Human Coagulation Factor VIII Consumption Market Share by Type (2013-2018)
Figure Americas Human Coagulation Factor VIII Consumption Market Share by Type in 2017
Table Americas Human Coagulation Factor VIII Consumption by Application (2013-2018) (K Units)
Table Americas Human Coagulation Factor VIII Consumption Market Share by Application (2013-2018)
Figure Americas Human Coagulation Factor VIII Consumption Market Share by Application in 2017
Figure United States Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure United States Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Canada Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Canada Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Mexico Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Mexico Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Table APAC Human Coagulation Factor VIII Consumption by Countries (2013-2018) (K Units)
Table APAC Human Coagulation Factor VIII Consumption Market Share by Countries (2013-2018)
Figure APAC Human Coagulation Factor VIII Consumption Market Share by Countries in 2017
Table APAC Human Coagulation Factor VIII Value by Countries (2013-2018) ($ Millions)
Table APAC Human Coagulation Factor VIII Value Market Share by Countries (2013-2018)
Figure APAC Human Coagulation Factor VIII Value Market Share by Countries in 2017
Table APAC Human Coagulation Factor VIII Consumption by Type (2013-2018) (K Units)
Table APAC Human Coagulation Factor VIII Consumption Market Share by Type (2013-2018)
Figure APAC Human Coagulation Factor VIII Consumption Market Share by Type in 2017
Table APAC Human Coagulation Factor VIII Consumption by Application (2013-2018) (K Units)
Table APAC Human Coagulation Factor VIII Consumption Market Share by Application (2013-2018)
Figure APAC Human Coagulation Factor VIII Consumption Market Share by Application in 2017
Figure China Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure China Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Japan Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Japan Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Korea Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Korea Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure India Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure India Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Australia Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Australia Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Table Europe Human Coagulation Factor VIII Consumption by Countries (2013-2018) (K Units)
Table Europe Human Coagulation Factor VIII Consumption Market Share by Countries (2013-2018)
Figure Europe Human Coagulation Factor VIII Consumption Market Share by Countries in 2017
Table Europe Human Coagulation Factor VIII Value by Countries (2013-2018) ($ Millions)
Table Europe Human Coagulation Factor VIII Value Market Share by Countries (2013-2018)
Figure Europe Human Coagulation Factor VIII Value Market Share by Countries in 2017
Table Europe Human Coagulation Factor VIII Consumption by Type (2013-2018) (K Units)
Table Europe Human Coagulation Factor VIII Consumption Market Share by Type (2013-2018)
Figure Europe Human Coagulation Factor VIII Consumption Market Share by Type in 2017
Table Europe Human Coagulation Factor VIII Consumption by Application (2013-2018) (K Units)
Table Europe Human Coagulation Factor VIII Consumption Market Share by Application (2013-2018)
Figure Europe Human Coagulation Factor VIII Consumption Market Share by Application in 2017
Figure Germany Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Germany Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure France Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure France Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure UK Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure UK Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Italy Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Italy Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Russia Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Russia Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Spain Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Spain Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Human Coagulation Factor VIII Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Countries in 2017
Table Middle East & Africa Human Coagulation Factor VIII Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Human Coagulation Factor VIII Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Human Coagulation Factor VIII Value Market Share by Countries in 2017
Table Middle East & Africa Human Coagulation Factor VIII Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Type in 2017
Table Middle East & Africa Human Coagulation Factor VIII Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Application in 2017
Figure Egypt Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Egypt Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure South Africa Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure South Africa Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Israel Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Israel Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure Turkey Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure Turkey Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Human Coagulation Factor VIII Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Human Coagulation Factor VIII Value Growth 2013-2018 ($ Millions)
Table Human Coagulation Factor VIII Distributors List
Table Human Coagulation Factor VIII Customer List
Figure Global Human Coagulation Factor VIII Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Human Coagulation Factor VIII Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Human Coagulation Factor VIII Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Human Coagulation Factor VIII Consumption Market Forecast by Regions
Table Global Human Coagulation Factor VIII Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Human Coagulation Factor VIII Value Market Share Forecast by Regions
Figure Americas Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Americas Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure APAC Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure APAC Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Europe Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Europe Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Middle East & Africa Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Middle East & Africa Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure United States Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure United States Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Canada Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Canada Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Mexico Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Mexico Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Brazil Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Brazil Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure China Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure China Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Japan Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Japan Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Korea Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Korea Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Southeast Asia Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Southeast Asia Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure India Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure India Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Australia Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Australia Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Germany Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Germany Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure France Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure France Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure UK Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure UK Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Italy Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Italy Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Russia Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Russia Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Spain Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Spain Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Egypt Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Egypt Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure South Africa Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure South Africa Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Israel Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Israel Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure Turkey Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure Turkey Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Figure GCC Countries Human Coagulation Factor VIII Consumption 2018-2023 (K Units)
Figure GCC Countries Human Coagulation Factor VIII Value 2018-2023 ($ Millions)
Table Global Human Coagulation Factor VIII Consumption Forecast by Type (2018-2023) (K Units)
Table Global Human Coagulation Factor VIII Consumption Market Share Forecast by Type (2018-2023)
Table Global Human Coagulation Factor VIII Value Forecast by Type (2018-2023) ($ Millions)
Table Global Human Coagulation Factor VIII Value Market Share Forecast by Type (2018-2023)
Table Global Human Coagulation Factor VIII Consumption Forecast by Application (2018-2023) (K Units)
Table Global Human Coagulation Factor VIII Consumption Market Share Forecast by Application (2018-2023)
Table Global Human Coagulation Factor VIII Value Forecast by Application (2018-2023) ($ Millions)
Table Global Human Coagulation Factor VIII Value Market Share Forecast by Application (2018-2023)
Table Shire (Baxter) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shire (Baxter) Human Coagulation Factor VIII Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Human Coagulation Factor VIII Market Share (2016-2018)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Human Coagulation Factor VIII Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Human Coagulation Factor VIII Market Share (2016-2018)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Grifols Human Coagulation Factor VIII Market Share (2016-2018)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biogen Human Coagulation Factor VIII Market Share (2016-2018)
Table Octapharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Octapharma Human Coagulation Factor VIII Market Share (2016-2018)
Table NovoNordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure NovoNordisk Human Coagulation Factor VIII Market Share (2016-2018)
Table Greencross Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Greencross Human Coagulation Factor VIII Market Share (2016-2018)
Table Kedrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Kedrion Human Coagulation Factor VIII Market Share (2016-2018)
Table BPL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table RAAS Basic Information, Manufacturing Base, Sales Area and Its Competitors


More Publications